Literature DB >> 36124177

Novel technique of penetrating keratoplasty in high-risk grafts with significant corneal neovascularization.

Mohammad Soleimani1, Nader Mohammadi1, Mansoor Shahriari2, Morteza Karimi1, Ahmed Alshaheeb1, Atefeh Khalili1, Mohammad Hossein Zamani1, Kasra Cheraqpour1.   

Abstract

Entities:  

Year:  2022        PMID： 36124177      PMCID： PMC9453411          DOI： 10.18240/ijo.2022.09.21

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.645


× No keyword cloud information.
  6 in total

1.  Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty.

Authors:  Theofilos Tourtas; Kathrin Laaser; Bjoern O Bachmann; Claus Cursiefen; Friedrich E Kruse
Journal:  Am J Ophthalmol       Date:  2012-03-06       Impact factor: 5.258

2.  Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment.

Authors:  O C Alldredge; J H Krachmer
Journal:  Arch Ophthalmol       Date:  1981-04

Review 3.  Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation.

Authors:  Deniz Hos; Mario Matthaei; Felix Bock; Kazuichi Maruyama; Maria Notara; Thomas Clahsen; Yanhong Hou; Viet Nhat Hung Le; Ann-Charlott Salabarria; Jens Horstmann; Bjoern O Bachmann; Claus Cursiefen
Journal:  Prog Retin Eye Res       Date:  2019-07-03       Impact factor: 21.198

Review 4.  Immune privilege in corneal transplantation.

Authors:  Junko Hori; Takefumi Yamaguchi; Hiroshi Keino; Pedram Hamrah; Kazuichi Maruyama
Journal:  Prog Retin Eye Res       Date:  2019-04-20       Impact factor: 21.198

Review 5.  Immune Privilege and Eye-Derived T-Regulatory Cells.

Authors:  Hiroshi Keino; Shintaro Horie; Sunao Sugita
Journal:  J Immunol Res       Date:  2018-05-20       Impact factor: 4.818

Review 6.  Corneal Allografts: Factors for and against Acceptance.

Authors:  Justyna Sakowska; Paulina Glasner; Maciej Zieliński; Piotr Trzonkowski; Leopold Glasner
Journal:  J Immunol Res       Date:  2021-10-03       Impact factor: 4.818
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.